Disposable Insulin-Delivery Device Market Growth at 7.6% CAGR, Surpassing US$ 32,814 Million by 2033 | FMI

The global market for disposable insulin-delivery devices achieved a valuation of US$ 14,585.6 million in 2022. As we step into 2023, the market is poised to increase further, with an estimated value of approximately US$ 15,780.6 million. Over the next decade, the sales of these devices on a global scale are anticipated to demonstrate a robust compound annual growth rate (CAGR) of 7.6%. By the end of this forecast period, the market is projected to reach an impressive total valuation of US$ 32,814 million. This growth can be attributed to the escalating expenditures on diabetes-related healthcare in emerging economies.

According to the International Diabetes Federation (IDF), one-tenth of the total population affected by diabetes has Type 1, and 10% of these individuals do not currently use insulin delivery devices, implying that the Disposable Insulin-Delivery Device market has significant potential for growth during the forecast period.

Claim Your Report – Featuring Captivating Visuals Inside!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5059

Pens are currently the most prevalent insulin delivery technology, accounting for more than 36% of the market when compared to syringes, pumps, and jet injectors. Pens’ design and ease of use have contributed to their widespread use. NovoPen is now the market leader, with a memory function as an extra bonus.

The principal end-user of Disposable Insulin-Delivery Devices is home care, which accounts for more than 45% of the market. The cost-effectiveness of home care over hospital treatment is a major contributor to this trend. Furthermore, the portability of these gadgets adds to their use for home care application. Future industry Insights did an in-depth analysis of the Disposable Insulin-Delivery Device industry, encompassing both micro and macro variables, in their latest market study titled ‘Disposable Insulin-Delivery Device Market.’

Key Takeaways from Disposable Insulin-Delivery Device Market

• North America has a 33% market share. Rising diabetes rates, credible government programmes, and the emergence of many disposable insulin delivery device manufacturers could all contribute to this. Diabetes affects more than 37 million people in the United States, according to the CDC.
• As a result of advances in healthcare infrastructure throughout Europe, Europe today controls 29% of the market. Diabetes was diagnosed in about 32 million persons in the EU in 2019.
• Rising diabetes awareness is one of the key forces driving the Disposable Insulin-Delivery Device market in the Asia-Pacific region, and this trend is expected to continue.

Key Players:

• Animas Corporation
• F. Hoffmann-La Roche AG
• Insulet Corporation
• Medtronic Plc.
• Valeritas, Inc.,
• Tandem Diabetes Care, Inc.
• Johnson & Johnson
• Beta Bionics Inc.
• Abbott Laboratories
• Becton Dickinson & Co.
• EyeSense GmbH

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5059

Competitive Landscape

• In February 2022, Abbott announced a partnership with Fitterfly, HealthifyMe, Zyla Health, 1MG, GOQii, PharmEasy, Sugar.fit, and BeatO as a step towards holistic diabetes control treatment. Abbott provides glucose monitoring solutions to over 8 million diabetes patients through collaborations, with 6.5 million having access to 1MG and PharmEasy.
• Insulet Corp. announced in January 2022 that the new Omnipod 5 system had been approved by the US FDA, introducing it into the field of AID (automated insulin delivery).
• In March 2022, Novo Nordisk announced the availability of two smart linked insulin pens called ‘NovoPen Echo Plus’ and ‘NovoPen 6’ for patients receiving Novo Nordisk insulin in the UK.
• Sanofi and Roche will collaborate in November 2021 to increase the usage of disposable insulin pens. Local players are also being approached in order to expand market penetration.

“A large chunk of the population is contracting diabetes, which asks for Disposable Insulin-Delivery Devices”, thereby accelerating the market for the same”, says an analyst from Future Market Insights.

What does the Report have at its discretion?

• In its latest analysis, Future Market Insights provides an exclusive perspective and numerous real-time data on the Disposable Insulin-Delivery Device market, presenting historical demand assessments from 2016 to 2021 and predictions from 2022 to 2032.
• The study is divided into three sections: product type (disposable insulin-delivery pumps, disposable insulin-delivery patches, disposable insulin-delivery pens, and disposable insulin-delivery syringes), illness indication (type I and type II diabetes), and distribution channel (hospital pharmacies, retail pharmacies, online sales, and diabetes clinics).
• With an increase in the number of diabetic patients as a result of obesity, aging, and sedentary lifestyles, the global Disposable Insulin-Delivery Device market is poised to make waves in the healthcare industry in the next years.

Want more insights:

In North America, the market is mature and dominated by established players such as Novo Nordisk and Eli Lilly. The increasing prevalence of diabetes, favorable reimbursement policies, and the availability of Advanced Insulin Delivery Technologies have been the key drivers of market growth in this region.

Key Segments Profiled in the Disposable Insulin-Delivery Device Market

Disposable Insulin-Delivery Device Market by Product Type:

• Disposable Insulin-Delivery Pumps
• Disposable Insulin-Delivery Patches
• Disposable Insulin-Delivery Pens
• Disposable Insulin-Delivery Syringes

Disposable Insulin-Delivery Device Market by Disease Indication:

• Disposable Insulin-Delivery Devices for Type I Diabetes
• Disposable Insulin-Delivery Devices for Type II Diabetes

Disposable Insulin-Delivery Device Market by Distribution Channel:

• Disposable Insulin-Delivery Devices Sales via Hospital Pharmacies
• Disposable Insulin-Delivery Devices Sales via Retail Pharmacies
• Disposable Insulin-Delivery Devices Sales via Online Sales
• Disposable Insulin-Delivery Devices Sales via Diabetes Clinics

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube